Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
AstraZeneca shares slump after $400bn BMS merger rumours
One of the largest global pharma companies would be created if a deal were to materialise.
Read Full Article
Express Pharma
Encube Ethicals files DRHP with SEBI for Rs 3,000 crore IPO
IPO comprises an offer for sale by promoters and investor selling shareholder through the book-building process. The post Encube Ethicals files DRHP with SEBI for Rs 3,000 crore IPO appeared first on Express Pharma.
Read Full Article
Express Pharma
Eisai launches LEQEMBI in India for early Alzheimer’s disease treatment
Launch follows CDSCO marketing authorisation for disease-modifying therapy indicated for patients with mild cognitive impairment and mild dementia due to early Alzheimer’s disease The post Eisai launches LEQEMBI in India for early Alzheimer’s disease treatment appeared first on Express Pharma.
Read Full Article
Pharma Tech
What will health and social care look like under Andy Burnham?
New UK PM Andy Burnham enters office with experience of the health sector, having previously been health secretary under Gordon Brown.
Read Full Article
Pharma Tech
IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib
IMPACT Therapeutics and Pharmanovia have entered an exclusive licensing deal worth up to $488.3m, giving Pharmanovia rights to manufacture, develop, and commercialise senaparib in 66 countries.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Aug 3, 2026, 3:03 PM
AstraZeneca shares slump after $400bn BMS merger rumours
One of the largest global pharma companies would be created if a deal were to materialise.
PharmaShots
Aug 3, 2026, 12:30 PM
Invenio Imaging Completes Enrollment in Pivotal ON-SITE Study for NIO Lung Cancer Reveal
Shots: Ref: PRnewswire | Image: Invenio Imaging | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Invenio Imaging Completes Enrollment in Pivotal ON-SITE Study for NIO Lung Cancer Reveal appeared first on PharmaShots.
PharmaShots
Aug 3, 2026, 11:30 AM
Meitheal Secures FDA Approval for Garzulys (Biosimilar, NovoLog)
Shots: Ref: Businesswire | Image: Meitheal | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Meitheal Secures FDA Approval for Garzulys (Biosimilar, NovoLog) appeared first on PharmaShots.
PharmaShots
Aug 3, 2026, 10:30 AM
Leads Biolabs Reports NMPA IND Clearnce to Initiate P-Ib/II Trial for Opamtistomig Combination Therapy in mCRC
Shots: Ref: Globenewswire | Image: Leads Biolabs | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Leads Biolabs Reports NMPA IND Clearnce to Initiate P-Ib/II Trial for Opamtistomig Combination Therapy in mCRC appeared first on PharmaShots.
Express Pharma
Aug 3, 2026, 10:21 AM
Encube Ethicals files DRHP with SEBI for Rs 3,000 crore IPO
IPO comprises an offer for sale by promoters and investor selling shareholder through the book-building process. The post Encube Ethicals files DRHP with SEBI for Rs 3,000 crore IPO appeared first on Express Pharma.
Express Pharma
Aug 3, 2026, 10:16 AM
Eisai launches LEQEMBI in India for early Alzheimer’s disease treatment
Launch follows CDSCO marketing authorisation for disease-modifying therapy indicated for patients with mild cognitive impairment and mild dementia due to early Alzheimer’s disease The post Eisai launches LEQEMBI in India for early Alzheimer’s disease treatment appeared first on Express Pharma.
News
Latest industry coverage
Google News
Aug 3, 2026, 8:36 PM
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Arrowhead Pharmaceuticals, Inc.
Google News
Aug 3, 2026, 8:34 PM
Amgen Tells SEC Hack Exposed Patient Data, Trade Secrets - GovInfoSecurity
Amgen Tells SEC Hack Exposed Patient Data, Trade Secrets GovInfoSecurity
Google News
Aug 3, 2026, 8:24 PM
What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today? - MarketScale
What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today? MarketScale
Google News
Aug 3, 2026, 8:06 PM
Vertex raises annual revenue forecast on cystic fibrosis drugs strength - Reuters
Vertex raises annual revenue forecast on cystic fibrosis drugs strength Reuters
Google News
Aug 3, 2026, 8:05 PM
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire
Google News
Aug 3, 2026, 8:04 PM
AstraZeneca and Bristol Myers Squibb Held Merger Talks | PharmExec - Pharmaceutical Executive
AstraZeneca and Bristol Myers Squibb Held Merger Talks | PharmExec Pharmaceutical Executive
Google News
Aug 3, 2026, 8:00 PM
Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines - Medical Xpress
Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines Medical Xpress
Google News
Aug 3, 2026, 7:56 PM
Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company - MedCity News
Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company MedCity News
Google News
Aug 3, 2026, 7:00 PM
AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal - The Globe and Mail
AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal The Globe and Mail
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer